MedPath

Healthy4Baby: Preventing Postpartum Weight Retention Among Low-Income, Black Women

Phase 2
Completed
Conditions
Pregnancy
Behavioral
Obesity
Weight Loss
Interventions
Behavioral: Healthy Lifestyle Group
Registration Number
NCT01530776
Lead Sponsor
Temple University
Brief Summary

The purpose of this study is to assess the feasibility and efficacy of an electronically-mediated, pregnancy and postpartum, behavioral intervention program, compared to usual obstetric care, on changes in weight and cardiometabolic biomarkers among overweight and obese Black women.

Detailed Description

Black women are in particular need for obesity prevention and treatment. Targeting the childbearing period has the potential to slow the accumulation of weight gain among this high risk group. Previous interventions to prevent postpartum weight retention among Blacks are sparse and limited by poor intervention adherence, high attrition, and failure to include pregnancy in the study design. The proposed research aims to overcome these shortcomings by developing an intervention that 1) focuses solely on Black women, 2) incorporates Black mothers' information needs, values, and social context, 3) uses technology to facilitate participant engagement, and 4) includes both the pregnancy and postpartum periods.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
66
Inclusion Criteria
  1. Pregnant African-American women at least 18 years of age
  2. BMI at recruitment between 25.0-44.9 kg/m2
  3. Singleton pregnancy
  4. Gestational age of ≤ 20 weeks as determined by last menstrual period
  5. Plan to carry the pregnancy to term and keep the baby
  6. Own a cell phone with a text messaging plan
  7. Member of Facebook social networking site
  8. Able to participate in physical activity
  9. Participants must be willing to comply with all study-related procedures
Exclusion Criteria
  1. BMI ≤ 24.9 or ≥ 45.0
  2. Uncontrolled hypertension (systolic blood pressure > 160 or diastolic blood pressure > 95 mmHg). Participants with controlled hypertension on medication for at least three months are allowable.
  3. Known atherosclerotic cardiovascular disease
  4. Known congestive heart failure
  5. Known diabetes mellitus (type 1 or type 2)
  6. Uncontrolled thyroid disease. Participants with controlled thyroid disease on medication for at least three months are allowable.
  7. Known cancer
  8. Any major active rheumatologic, pulmonary, hepatic, dermatologic disease or inflammatory condition requiring steroids or immune modulating medications
  9. History of testing HIV positive
  10. Current smoker or tobacco user
  11. Current or recent history (past 6 months) of drug or alcohol abuse or dependence
  12. Participation in any weight control or investigational drug study within 6 weeks of screening
  13. Serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's safety for successful study participation
  14. Gastrointestinal Disorders (gallbladder disease, Crohn's disease, etc)
  15. Previous weight loss surgery
  16. History of bulimia or anorexia

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Healthy Lifestyle GroupHealthy Lifestyle GroupParticipants randomized to this condition will receive information and strategies to help them eat healthier and be more active during and after pregnancy. They will get this information about eating and activity through handouts, text messages, Facebook updates, and in-person visits and phone calls from a health coach.
Primary Outcome Measures
NameTimeMethod
Change in maternal weight from early pregnancy (< 20 weeks gestation) to 6 months and 1 year postpartumApproximately 18 months
Secondary Outcome Measures
NameTimeMethod
Change in maternal weight from early pregnancy to deliveryApproximately 6 months
Change in maternal cardiometabolic biomarkers and additional anthropometrics (insulin sensitivity and secretion, fasting lipids, blood pressure, waist circumference) from early pregnancy to 6 months and 1 year postpartumApproximately 18 months
Change in infant weight and length from birth to 6 months and 1 year of ageApproximately 12 months

Trial Locations

Locations (1)

Temple University

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath